Optimal treatment strategies for community-acquired pneumonia: Non-responders to conventional regimens

被引:7
作者
File, TM [1 ]
机构
[1] Northeastern Ohio Univ Coll Med & Pharm, Coll Med, Dept Internal Med, Rootstown, OH 44272 USA
关键词
community-acquired pneumonia; CAP; failure of therapy; fluoroquinolones; levofloxacin;
D O I
10.1159/000049175
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
When patients with community-acquired pneumonia (CAP) fail to respond after initiation of empirical therapy, it is necessary for the physician to consider a number of possibilities. The diagnosis should be reviewed, with consideration given to both non-infectious and infectious illnesses. If the diagnosis is correct, the failure may relate to three areas: host-related problems, including overwhelming infection and empyema, pathogen-related problems, including infection caused by an unusual or resistant pathogen, and drug-related problems, including inappropriate dose of drug, poor compliance, malabsorption, and drug interactions. A systematic therapeutic approach including a microbiological evaluation to identify the causative pathogen and its susceptibility will help to ensure that an appropriate antimicrobial agent is used. Copyright (C) 2001 S. KargerAG, Basel.
引用
收藏
页码:11 / 18
页数:8
相关论文
共 14 条
[1]   ANTIMICROBIAL RESISTANCE IN STREPTOCOCCUS-PNEUMONIAE - AN OVERVIEW [J].
APPELBAUM, PC .
CLINICAL INFECTIOUS DISEASES, 1992, 15 (01) :77-83
[2]   Antimicrobial treatment failures in patients with community-acquired pneumonia - Causes and prognostic implications [J].
Arancibia, F ;
Ewig, S ;
Martinez, JA ;
Ruiz, M ;
Bauer, T ;
Marcos, MA ;
Mensa, J ;
Torres, A .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (01) :154-160
[3]  
Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954
[4]   Epidemiological features of and risk factors for infection by Streptococcus pneumoniae strains with diminished susceptibility to penicillin: Findings of a French survey [J].
Bedos, JP ;
Chevret, S ;
Chastang, C ;
Geslin, P ;
Regnier, B .
CLINICAL INFECTIOUS DISEASES, 1996, 22 (01) :63-72
[5]  
FILE TM, 1997, AM J MED CONTINUING
[6]  
JACOBS MR, 1999, 39 ANN M INT C ANT A
[7]  
Kahn James B., 2000, Chest, V118, p236S
[8]   ANTIMICROBIAL RESISTANCE IN STREPTOCOCCUS-PNEUMONIAE - A SOUTH-AFRICAN PERSPECTIVE [J].
KOORNHOF, HJ ;
WASAS, A ;
KLUGMAN, K .
CLINICAL INFECTIOUS DISEASES, 1992, 15 (01) :84-94
[9]   TRENDS IN ANTIMICROBIAL RESISTANCE OF CLINICAL ISOLATES OF STREPTOCOCCUS-PNEUMONIAE IN BELLVITGE-HOSPITAL, BARCELONA, SPAIN (1979-1990) [J].
LINARES, J ;
PALLARES, R ;
ALONSO, T ;
PEREZ, JL ;
AYATS, J ;
GUDIOL, F ;
VILADRICH, PF ;
MARTIN, R .
CLINICAL INFECTIOUS DISEASES, 1992, 15 (01) :99-105
[10]   Guidelines for community-acquired pneumonia: A tale of 2 countries [J].
Mandell, LA .
CLINICAL INFECTIOUS DISEASES, 2000, 31 (02) :422-425